Abbott sees the delivery system as a differentiator for its TAVR, and this is a great strategic choice on the part of Abbott. They've made the decision to improve all aspects of their Portico TAVR device, not just the valve itself. TAVR is a bare knuckles fighting market. But, if you make the device easier to use and place, it can grab a critical share of market for your product. Santosh Prabhu—divisional VP, product development of Abbott Structural Heart outlined 5 ways they improved the delivery system for the Portico device…
Manufacturing And Supply Chain Strategy Changes For Biotech/Pharma Post-COVID?
Infographic: Online Medtech Human Factors Usability Testing during COVID-19
CONTACT US
LOOKING FOR A PARTNER WITH KEY INSIGHTS FROM CLINICIANS & HOSPITAL ADMINISTRATORS AND HOSPITAL CFOS?
OUR LAST THREE PROJECTS WERE:
What price premium can be charged for an upgraded legacy product in a commodity space?
Medtech price sensitivity analysis - hospital administrators and CFOs
M&A due diligence analysis: pricing for a new disruptive product
Maximize profit with medical device price strategy research
Justifying an increased price is always a challenge in the medical device space. But, if the next generation feature set warrants a price increase, we can help your marketing teams articulate and quantify your product’s value.